Can Multimedia Lead to More Informed Decisions on Prostate Cancer Treatment?
March 15, 2010 by Prostate Dr. · Comments Off
Watson Pharmaceuticals’ TRELSTAR receives FDA approval for treatment of advanced prostate cancer
Watson Pharmaceuticals, Inc., today announced the U.S. Food and Drug Administration approval of TRELSTAR® 22.5 mg (triptorelin pamoate for injectable suspension), a new twice-yearly formulation of TRELSTAR®, a proven, simple and effective palliative treatment of advanced prostate cancer.
Read more on News-Medical-Net
Can Multimedia Lead to More Informed Decisions on Prostate Cancer Treatment?
Mount Sinai School of Medicine is leading a study…
